Astera Labs
$356.42Change from previous close: +0.13%Absolute change: +$0.45
At a glance
- Revenue growth
- +115.13%
- 2025 vs 2024
- Net margin
- 25.7%
- 2024: -21.1%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 853 | 396 | 116 | 79.9 |
| Cost of revenue | 207 | 93.6 | 36.0 | 21.2 |
| Gross profit | 645 | 303 | 79.8 | 58.7 |
| Selling, general and administrative | 168 | 218 | 35.9 | 45.2 |
| Research and development | 304 | 201 | 73.4 | 73.7 |
| Operating income | 173 | -116 | -29.5 | -60.2 |
| EBIT | 173 | -116 | -29.5 | -60.2 |
| EBITDA | 180 | -113 | -27.7 | -59.4 |
| Pre-tax income | 218 | -81.8 | -22.9 | -57.6 |
| Income tax | -1.0 | 1.6 | 3.3 | 0.8 |
| Net income | 219 | -83.4 | -26.3 | -58.3 |
| Net income to common shareholders | 219 | -83.4 | -26.3 | -58.3 |
| Basic EPS | 1.32 | -0.64 | -0.71 | -1.71 |
| Diluted EPS | 1.22 | -0.64 | -0.71 | -1.71 |
| Average shares (basic) | 166 | 131 | 37.1 | 34.2 |
| Average shares (diluted) | 180 | 131 | 37.1 | 34.2 |